Add to ORKGAnalyzing the process of caring for NSCLC patients is feasible and offers room for improvement. Acquired knowledge may be shared with hospital administrators, guide the revision of ICPs, and enable the delivery of consistent, high-quality clinical standard
More than 170 000 new cases and 150 000 deaths have occurred in 2003 in US owing to lung cancer, whi...
The diagnosis and treatment of lung cancer is challenged by complex diagnostic pathways and fragment...
Eliot L Friedman,1 Robert J Kruklitis,2 Brian J Patson,1 Dennis M Sopka,3 Michael J Weiss4 1Division...
Introduction:Integrated care pathways (ICPs) have been proposed as effective strategies for quality ...
The management of non-small cell lung cancer (NSCLC) has evolved into a multidiscipli-nary team appr...
Introduction: Much of the existing work around implementation of cancer optimal care pathways (OCP) ...
Introduction: The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, pa...
Lung cancer is a diagnosis that has risen to the top of the global cancer death toll. Adenocarcinoma...
BACKGROUND: In the current study, the authors focused on determinants influencing the quality of car...
The management of non-small-cell-lung-cancer (NSCLC) has evolved into a multidisciplinary team appro...
Lung cancer is a common disease with approximately 3-million new cases per year worldwide and is the...
Non-small cell lung cancer (NSCLC) accounts for approximately one in five cancer-related deaths, and...
BACKGROUND: Oncologists use Via Pathways (VP) to drive standardization to best evidence-based cancer...
In the United States, lung cancer is currently the leading cause of cancer mortality, with nearly 16...
Non-small cell lung cancer (NSCLC) accounts for approximately one in five cancer-related deaths, and...
More than 170 000 new cases and 150 000 deaths have occurred in 2003 in US owing to lung cancer, whi...
The diagnosis and treatment of lung cancer is challenged by complex diagnostic pathways and fragment...
Eliot L Friedman,1 Robert J Kruklitis,2 Brian J Patson,1 Dennis M Sopka,3 Michael J Weiss4 1Division...
Introduction:Integrated care pathways (ICPs) have been proposed as effective strategies for quality ...
The management of non-small cell lung cancer (NSCLC) has evolved into a multidiscipli-nary team appr...
Introduction: Much of the existing work around implementation of cancer optimal care pathways (OCP) ...
Introduction: The COVID-19 pandemic has proved to be a historic challenge for healthcare systems, pa...
Lung cancer is a diagnosis that has risen to the top of the global cancer death toll. Adenocarcinoma...
BACKGROUND: In the current study, the authors focused on determinants influencing the quality of car...
The management of non-small-cell-lung-cancer (NSCLC) has evolved into a multidisciplinary team appro...
Lung cancer is a common disease with approximately 3-million new cases per year worldwide and is the...
Non-small cell lung cancer (NSCLC) accounts for approximately one in five cancer-related deaths, and...
BACKGROUND: Oncologists use Via Pathways (VP) to drive standardization to best evidence-based cancer...
In the United States, lung cancer is currently the leading cause of cancer mortality, with nearly 16...
Non-small cell lung cancer (NSCLC) accounts for approximately one in five cancer-related deaths, and...
More than 170 000 new cases and 150 000 deaths have occurred in 2003 in US owing to lung cancer, whi...
The diagnosis and treatment of lung cancer is challenged by complex diagnostic pathways and fragment...
Eliot L Friedman,1 Robert J Kruklitis,2 Brian J Patson,1 Dennis M Sopka,3 Michael J Weiss4 1Division...